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Abstract 
Changes in the myocardial energetics associated with aging—reductions in creatine phosphate (CrP)/ATP ratio, 
total creatine, and ATP—mirror changes observed in failing hearts compared to healthy controls. Similarly, both 
aging and heart failure are associated with significant reductions in cardiac performance and maximal left ventric-
ular cardiac power output (CPO) compared to young healthy individuals. Based on these observations, we hy-
pothesize that reductions in the concentrations cytoplasmic adenine nucleotide, creatine, and phosphate pools that 
occur with aging impair the myocardial capacity to synthesize ATP at physiological free energy levels, and that 
the resulting changes to myocardial energetic status impair the mechanical pumping ability of the heart. The pur-
pose of this study is to test theses hypotheses using an age-structured population model for myocardial metabo-
lism in the adult female population and to determine the potential impact of reductions in key myocardial metabo-
lite pools in causing metabolic/energetic and cardiac mechanical dysfunction associated with aging. To test these 
hypotheses, we developed a population model for myocardial energetics to predict myocardial ATP, ADP, CrP, 
creatine, and inorganic phosphate concentrations as functions of cardiac work and age in the adult female popula-
tion. Model predictions support our hypotheses and are consistent with previous experimental observations. The 
major findings provide a novel theoretical and computational framework for further probing complex relation-
ships between the energetics and performance of the heart with aging.  
Significance  
Normal mechanical function of the heart requires that ATP be continuously synthesized at a hydrolysis potential 
of roughly -60 kJ mol-1. Yet in both the aging and diseased heart the relationships between cardiac work rate and 
concentrations of ATP, ADP, and inorganic phosphate are altered. Important outstanding questions are: To what 
extent do changes in metabolite concentrations that occur in aging and heart disease affect metabolic/molecular 
processes in the myocardium? How is myocardial mechanical function affected by changes in metabolite concen-
trations? This study addresses these questions by analyzing relationships between cardiac energy demand and 
supply using an age-structured population model for human myocardial energetics in women. 
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Introduction 
Peak left ventricular cardiac power output (CPO), as an integrative measure of overall pumping capability and 
performance of the heart,  is the strongest predictor of mortality in heart failure [1]. Yet even in the absence of 
heart failure, maximal CPO decreases with age and thus increases the risk cardiovascular morbidity and mortality 
[2]. Changes in myocardial energetics with age are associated with diminished maximal CPO in older people [3, 
4]. These observations raise the questions of if and how age-dependent changes to myocardial metabolic energy 
supply influence the myocardial capacity to generate power. Previous studies have established a theoretical link 
between reductions in cytoplasmic adenine nucleotide, creatine, and phosphate metabolite pools and altered myo-
cardial energetics in heart failure [5]. The goals of the present study are to determine whether or not reductions in 
these metabolite pools can potentially explain age-dependent changes in myocardial energetics in normal subjects 
and whether or not the resulting energetic changes can potentially explain the observed reductions in maximal 
CPO with age.  
Left ventricular CPO is the rate at which the ventricle produces mechanical work to pump blood through the sys-
temic circulation. CPO is calculated as left ventricular stroke work (mechanical work done per heart beat) multi-
plied by the heart rate, or as average difference in pressure between the left atrium and the aorta multiplied by the 
cardiac output, expressed in units of energy per unit time. Processes such as cross-bridge cycling require that ATP 
is continuously synthesized (and ADP and inorganic phosphate consumed) at sufficient concentrations such that 
normal functions are not kinetically or thermodynamically impaired [6, 7]. Because demand for ATP production 
in the myocardium is proportional to cardiac work, and because ATP hydrolysis serves as the source of chemical 
free energy to drive myocardial contraction, it stands to reason that limitations or impairments in myocardial en-
ergy metabolism may influence overall cardiac performance represented by CPO.  
It is observed that in both the aging [3, 4] and the diseased heart [8-12] relationships between cardiac work rate 
and concentrations of phosphate metabolites ATP, ADP, and phosphocreatine (CrP) are altered. In heart failure 
ATP and the CrP/ATP ratio is diminished and [ATP] in myocardium is lower compared to healthy individuals [8, 
12-14]. Although heart failure is a complex syndrome which can arise due to a variety of pathophysiological ab-
normalities [15], alterations to the myocardial energetics state are established hallmarks of heart failure irrespec-
tive of etiology [8, 13, 16, 17]. While a complete understanding of the mechanistic links between energy metabo-
lism and mechanical function is lacking, energy metabolism represents an actively pursued potential target for 
treating heart failure [18-21].  
Similarities between the myocardial energetic phenotypes observed in heart failure/decompensation and aging 
include lower myocardial ATP and CrP/ATP compared to the healthy young heart [4, 22]. Based on these similar-
ities and similarities in terms of diminished maximum cardiac performance, we hypothesize that reductions in the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
concentrations cytoplasmic adenine nucleotide, creatine, and phosphate pools that occur with aging impair the 
myocardial capacity to synthesize ATP at physiological free energy levels, and that the resulting changes to myo-
cardial energetic status play a causal role in contributing to reductions in cardiac performance with aging. 
To explore the viability of these hypotheses we applied a model of myocardial energetics previously used to ana-
lyze data from large animals [5, 23]. An age-structured population model for myocardial metabolite pools was 
parameterized based on studies in humans from Kostler et al. [22] and Jakovljevic et al. [3] to represent variability 
and interrelationships between adenine nucleotide, creatine, and phosphate pools in the human female population. 
The model of population variability in metabolite pools was used in conjunction with simulations of myocardial 
energetics to predict the relationship between maximum CPO and age. Because of a significant difference in age-
associated changes in cardiac morphology and function between men and women [2, 24, 25], the present model 
accounts for female subjects only. Model predictions are consistent with observations on the relationships be-
tween age and maximum CPO in female subjects [3, 4] and consistent with our hypotheses. These simulations 
provide a theoretical/computational framework for further probing relationships between energetic status and car-
diac power and for comparing predictions associated with the hypothesis and experimental data. 
Methods 
Overview of simulation methods 
A previously developed model of myocardial energetics developed by Wu et al. [5, 23] was used to simulate how 
myocardial oxygen consumption (??? ?) and cellular concentrations of ATP, ADP, inorganic phosphate (Pi), Cr, 
and CrP vary with changes in ATP demand. This model has been validated on the basis of its ability to match 
steady-state data on how these variables vary with changes in ATP demand under physiological conditions, how 
CrP and Pi levels change dynamically in response to acute ischemia and recovery, and how these variables are 
altered in response to changes in concentrations of key cytoplasmic metabolite pools. Using this underlying model 
framework, an age-structured population model for the total adenine nucleotide (TAN), total creatine (CRtot), and 
total exchangeable phosphate (TEP) metabolite pools is parameterized from data on resting myocardial CrP/ATP 
and [ATP] in healthy women aged 20-81 years [3, 22]. The relationship between ??? ? and CPO is determined 
empirically based on observations showing a linear relationship between oxygen consumption and power output 
over a broad range of physiological conditions in animal models and man.  
The Wu et al. model of myocardial energetics consists of 62 ordinary differential equations for state variables rep-
resenting cytoplasmic and mitochondrial TCA cycle intermediate concentrations, phosphate metabolites ATP, 
ADP, AMP, Pi, Cr, and CrP, mitochondrial membrane potential, and cations K+, Mg2+, and H+. The full set of 
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equations is provided in the supplementary material for Wu et al. [5], and Matlab codes for the model are dissem-
inated (http://virtualrat.org/models/steady-state-cardiac-energetics-control-left-ventricular-hypertrophy-lvh-
hearts). For applications described here, default normal parameter values are used, with conserved TAN, CRtot, 
and TEP metabolite pools varied as described below. Steady-state cytoplasmic energetic state (concentrations of 
ATP, ADP, Pi, etc.) are computed as functions of cytoplasmic ATP hydrolysis rate, to compute relationships be-
tween metabolite concentrations and oxygen consumption rate.  
Population myocardial energetics model 
The model of Wu et al. [5, 23] was used to simulate myocardial oxygen transport, mitochondrial tricarboxylic 
acid cycle kinetics and oxidative phosphorylation, and cytoplasmic adenylate kinase, creatine kinase, and ATP 
hydrolysis. Model predictions of how phosphate metabolite levels vary with ??? ? are illustrated in Figure 1 for 
20 year-old subjects. For these steady-state model simulations the ATP hydrolysis and ATP synthesis rates are 
equal and proportional to the rate of oxygen consumption. To obtain these results the ATP demand (the cellular 
ATP hydrolysis rate) is varied from 0.36 to 1?52 mmol·s−1·(l cell)−1. This range of ATP hydrolysis rate yields a 
range of ??? ? of 3.5 to 13.5 mmol·min-1·g-1 (or 78 to 302 μlO2·min-1·g-1). Since ??? ? ? 3.5 mmol·min-1·g-1 is 
the mean value of LV myocardial oxygen consumption observed in anesthetized dogs under baseline conditions in 
the data sets analyzed by Wu et al. [23] and ??? ? ? 13.5 mmol·min-1·g-1 represents the upper limit of LV oxy-
gen consumption in conscious exercising dogs [26], we use this range of ATP demand to capture upper and lower 
limits of the physiological range. Simulations summarized in Figure 1 shows that mean cytoplasmic inorganic 
phosphate concentration ([Pi]c) increases from 0.43 mM under resting conditions (??? ? ? 5.1 mmol·min-1·g-1
[27]) to 2.0 mM at a moderate exercise intensity (??? ? ? 10 mmol·min-1·g-1) to 4.3 mM at maximal exercise 
conditions (??? ? = 13.5 mmol·min-1·g-1), while the CrP/ATP ratio decreases from approximately 2.06 at rest to 
1.80 at ??? ? ? 10 mmol·min-1·g-1 and to 1.50 at maximal exercise. These concentration ranges correspond to the 
expected ranges based on available in vivo data [23, 28]. 
Predictions of the Wu et al. model depend on the levels of the three conserved metabolite pools: the total adenine 
nucleotide pool (TAN), the total exchangeable phosphate pool (TEP), and the total creatine pool (CRtot). These 
pools are defined as: 
??? ? ?????????????? ? ?????? ? ???????
? ?????????????? ? ?????? ? ???????
??????????????? ? ????????
??? ? ??????????????? ? ?????? ? ????? ? ???????
? ??????????????? ? ?????? ? ????? ? ???????
??????????????? ? ????? ? ????????
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????? ? ????????????? ? ???????? ????
where ????? and ????? are the cellular volume fraction of cytoplasm and mitochondria, respectively; ??, ????and 
?? are water volume fraction in cytoplasm, mitochondrial intermembrane space, and mitochondrial matrix, re-
spectively; solute concentration in different cellular region is represented by the solute name in a square bracket 
together with a subscript “c”, “i”, or “x” indicating cytoplasm, mitochondrial intermembrane space, and mito-
chondrial matrix, respectively. The values of volume fractions used in this study are from Wu et al. 
It is assumed that the mean level of each metabolite pool varies linearly with human age, and the distribution of 
pool level at each specific age follows the normal distribution. Thus, for an individual subject, the metabolite pool 
is defined with a linear model as: 
??? ? ??? ? ? ? ???? ? ?? ? ????
??? ? ??? ? ? ? ???? ? ?? ? ????
????? ? ??? ? ? ? ???? ? ?? ? ????
     (2) 
where A0, P0, C0, a, p, and c are parameters, and εa, εp, and εc are random variables assumed to follow normal dis-
tributions with a mean of zero and variances defined 
??
??
??
??
? ? ??? ?? ???? ? ?
??? ? ?
? ??? ????
? ???? ???
?.    (3) 
Equation (3) assumes that the variability in the phosphate and creatine pools are correlated (with correlation coef-
ficient σpc) while the adenine nucleotide pool varies independently of the other pools.  
Values of parameters A0, P0, C0, a, p, c, σa, σp, σc, and σpc are listed in Table 1. Values of these parameters were 
estimated as follows. The mean levels for all three metabolite pools in the 20-year-old population were assumed 
to be equal to the normal levels determined by Wu et al. [5]: 
??????????? ?? ? ?? ? ??? ? ?????? ???????????????
??????????? ?? ? ?? ? ??? ? ?????? ???????????????
????????????? ?? ? ?? ? ??? ? ?????? ???????????????
  (4) 
Furthermore, the relationship between a and p was fixed to maintain the average proportion between TAN and 
TEP determined by Wu et al.:  
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? ? ???????? ? ? ? ??       (5) 
Using the relationships defined in Equations (4) and (5), values of A0, P0, C0, and p and calculated from estimates 
of a and c. The six adjustable parameters (a, c, σa, σp, σc, and σpc) defining the age-dependent variability in the 
metabolite pools are estimated by fitting model predictions to data from Köstler et al. [22] and Jakovljevic et al.
[3], as detailed below. 
Population model results were obtained by randomly sampling the distributions of TAN, TEP, and CRtot governed 
by Equations (2) and (3). Results below were obtained by simulating 13 fixed-age groups representing ages from 
20 to 80 years. Within each age group 1000 independently determined individuals were simulated. Simulations 
representing the resting state are obtained setting the cellular ATP hydrolysis rate to 0.547?mmol·s−1·(l cell)−1, 
which yields a resting state ??? ? ? 5.1 mmol·min-1·(g tissue)-1. 
Summary of model assumptions 
In summary, simulations are based on the previously published model of Wu et al. [23] of cardiac energy metabo-
lism, which is validated in comparison to steady-state and transient data on phosphate metabolites from normal 
canine hearts in vivo, and from steady-state data on phosphate metabolites measured in vivo in a canine model of 
hypertrophy and decompensation following pressure overload [5]. Previously reported analyses of myocardial 
energetics in heart disease revealed that the observed reductions in ATP and CrP/ATP ratio may be explained by 
measured reductions in the TAN, CRtot, and TEP metabolite pools. Here, similar change in metabolic pools were 
imposed, based on Equation (2) to determine if and how changes in metabolite pools with age can explain chang-
es in myocyardial energetics and maximal cardiac power output with aging. Furthermore, to simulate the relation-
ship between energetics cardiac power, we use the assumption of constant cardiac efficiency (see below.) Thus 
there is no explicit model of myocardial mechanics, and it is assumed that cardiac mechanical efficiency is con-
stant and independent of age. The validity of this assumption is discussed in the Discussion. 
Results  
Steady state phosphate metabolite levels for healthy young individuals 
The model predictions show in Figure 1 (corresponding to a population of 20 year-old female subjects) reveal the 
expected trends of increasing ADP and inorganic phosphate with increasing ATP/oxygen demand. This in vivo 
relationship between ATP hydrolysis products and ATP synthesis rate has been shown to be effectively captured 
by an apparent random bi-bi mechanism [29] with apparent Michaelis-Menten constants for ADP and Pi of ap-
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proximately KADP = 21 μM and KPi = 1.1 mM [30, 31]. Thus the predicted ADP concentration is several fold high-
er than the apparent Michaelis-Menten constants for ADP over the whole range of in vivo ATP/oxygen demand, 
while ([Pi]c) increases from approximately half its apparent Michaelis-Menten constant at resting conditions 
(??? ? ? 5.1 mmol·min-1·g-1). Thus, the inorganic phosphate concentration is the more important of ATP hydrol-
ysis products in feedback stimulation of ATP synthesis [5, 23, 30-32]. Increasing cytoplasmic Pi with increasing 
ATP demand leads to increased matrix Pi, which leads to a greater diving force for phosphorylation of ADP in the 
matrix, which leads to a greater ATP/ADP level, which increases flux through the mitochondrial ATP/ADP trans-
locator, meeting the increased demand. 
Parameterization of population model 
The six adjustable parameters (a, c, σa, σp, σc, and σpc) in the population model are estimated by matching model 
predictions to data on resting-state myocardial energetics from Köstler et al. [22] and Jakovljevic et al. [3] in Fig-
ure 2. The mean model outputs are plotted as solid black lines. The light shaded areas represent the 90% confi-
dence range from the population prediction for each variable and the dark shaded areas represent the 50% confi-
dence range. The nonzero value of ???, the covariance between TEP and CRtot pool, indicates that higher than 
average total creatine tends to be accompanied by higher than average total phosphate. In fact, the estimated ???
is roughly equal to the geometric mean of ?? and ??, the relative variances in the TEP and CRtot pools, suggesting 
that these two metabolite pools are regulated to vary in proportion.  
Figure 2A compares results on resting CrP to ATP ratio to data from Jakovljevic et al. [3] obtained from 55 
healthy untrained women with age ranging from 21 to 81 years. The population model, defined based on Equa-
tions (2) and (3) effectively captures the trends observed by Jakovljevic et al. Data from 29 of the 55 individuals 
fall within the 50% confidence range. Data from 3 of the 55 individual fall outside of the 90% confidence range. 
Panels B and C of Figure 2 compare results on resting myocardial ATP and CrP levels to data from Köstler et al. 
[22] from 12 healthy women ranging from 21 to 64 years old. In panels B and C, simulations and data are report-
ed in terms of total ATP and CrP per mass of myocardium. The predicted decreases in CrP and ATP and with in-
creasing age are in good agreement with the trends in the data from Köstler et al.  
Panels E and F of Figure 2 plot the associated model predictions of cytoplasmic ADP ([ADP]c) and inorganic 
phosphate concentration ([Pi]c) which are reported here in units of millimoles per liter of myocyte cytoplasmic 
water space. As the TAN decreases with age, both the cytoplasmic ATP and ADP decrease. The median resting 
[ADP]c is predicted to decrease from 78 μM for a typical 20-year-old to 17 μM for a typical 80-year-old. Since 
ATP synthesis is primarily controlled by concentrations of ADP and Pi, lower ADP levels in older individuals is 
balanced by higher concentrations of free phosphate compared to younger individuals. The population model pre-
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dicts that resting-state cytoplasmic [Pi] increases from approximately 0.5 mM in 20-40 year-old individuals to 1.0 
mM in the mean 65 year-old, and to greater than 1 mM in most individuals aged 70 years and older. Thus, the 
population model predicts that, because of differences in conserved metabolite pool levels, the same resting ATP 
synthesis rate is associated with substantially different phosphate metabolite concentrations in young versus old 
individuals. The prediction of higher free phosphate, associated with lower ADP, in older compared to younger 
individuals, is intriguing in light of a potential link between increased plasma free phosphate levels and aging and 
cardiovascular disease risk [33-35]. Lower ATP and ADP levels are also predicted to be associated with lower 
AMP, and thus diminished AMP-dependent signaling, in older individuals. 
Predicted impacts of changes to cytoplasmic metabolic pools on the resting Gibbs free energy of ATP hydrolysis 
are shown in Figure 2 panel D. For the age range of 20-40 years, the estimated ΔGATP is approximately -65.5 
kJmol-1, equivalent to that estimated by Bazil et al. [17]. As free phosphate levels increase with age, the magni-
tude of the resting ΔGATP decreases, reflecting the higher [Pi]c required to maintain the same resting ATP demand 
in older compared to younger women. 
Prediction of maximum cardiac power output 
To predict maximal CPO the maximum ??? ? was estimated for each individual in the virtual populations by in-
creasing cytoplasmic ATP demand until the cytoplasmic inorganic phosphate concentration reached 4.4 mM, the 
value associated with the maximal ??? ? in the mean 30 year-old individual. The maximal ??? ? was converted 
to maximal CPO based on the proportionality between ??? ? and work : 
??? ? ?? ? ??? ? ? ?? ? ???     (6) 
where the myocardial external efficiency ε is set to 0.25 [36], ??? ? is expressed in units of mL·(second g tissue)-
1, the caloric equivalent of 1 mL of O2 is taken to be 20 Joules, and LVM is the LV mass set to 150 g.  
Figure 3 compares model-predicted maximum CPO to data from Jakovljevic et al. [3]. Both panels plot the model 
predictions as in Figures 1 and 2 with the light shaded areas represent the 90% confidence range from the popula-
tion prediction for each variable and the dark shaded areas represent the 50% confidence range. The left panel 
plots the individual data points as red dots. The right panel plots statistical summaries of the data for three age 
groups, showing mean age and mean maximum CPO, and with error bars indicating ± 1 standard deviation. The 
model predicts that from age 20 to 80, the mean maximum CPO drops from 3.87 to 2.83 W, in agreement with the 
trend observed by Jakovljevic et al. and Nathania et al. [4]. 
Similar to the resting state simulations in Figure 2, the majority of the data in Figure 3 falls within the 90% confi-
dence range, with 8 of the 55 individuals falling outside of the 90% range and 20 of 55 data points falling within 
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the 50% confidence range. The population model predicts an average drop of 0.48 W in maximum CPO from the 
middle age group (mean 44 years) to old group (mean 71 years), compared to an observed difference of 0.79 W. 
Maximum CPO falls below 2.2 W for roughly 25% of the simulated 80-year-old population, close to the value of 
1.96 W that has been identified as the cut-off associated with maximum relative risk ratio for mortality [1]. Max-
imum CPO falls below 1.96 W for 15.5% of the simulated 80-year-old population.  
Discussion 
Using an age-structured population model, the present study tested hypotheses that reductions in key cytosolic 
metabolite pools that occur with aging impair the myocardial capacity to synthesize ATP at physiological free 
energy levels, and that the resulting metabolic changes impair the mechanical pumping ability of the heart and its 
performance. Results support these hypotheses, as the model parameterized based on resting-state data predicts 
the observed relationships between age and mechanical and energetic performance of the heart in exercise. Specif-
ically, the population-level model of human cardiac energetics was parametrized to match data on resting-state 
energetics in healthy women aged 21 to 81.  
Similar approaches to generating populations of model parameterizations have been used by Britton et al. [37] and 
Sobie [38] to generate model populations representing variability in cardiomyocyte electrophysiology kinetics. 
Sobie introduced a method of sensitivity analysis combining random sampling of parameter values with least-
squares regressions models mapping parameter variability to variability in model outputs. Britton et al. used Latin 
hypercube sampling to generate uncorrelated random variability in parameters representing channel conductances 
and time constants, and then used comparisons to experimental data to explore relationships between variability in 
experimentally measured variables and the statistical structure of variability in the parameter space. Here, instead 
of first generating an unbiased uncorrelated parameter population and then later culling the parameter space based 
on comparisons to data, as done by Britton et al., we have assumed an a priori statistical structure for the variabil-
ity in metabolite pools, governed by parameters a, c, σa, σp, σc, and σpc. The statistical model is identified and val-
idated based on comparison to data in Figure 2. The validated virtual model population that is associated with pa-
rameter sets sampled from this statistical model is then used to explore how resting and exercise-state myocardial 
energetics varies in the population. 
Model simulations predict that metabolic supply capacity decreases with age, driven by changes in metabolic 
pools. Applying the assumption that maximum cardiac power output is limited by maximum metabolic supply 
yields predictions that are consistent with available data on reductions in maximum CPO with age, and are con-
sistent with the following specific hypotheses: 
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1. reductions in cytoplasmic adenine nucleotide, creatine, and phosphate pools that occur with aging impair 
the myocardial capacity to synthesize ATP at physiological free energy levels; and  
2. the resulting changes to myocardial energetic status play a causal role in contributing to reductions in 
maximal cardiac power output with aging.  
The potential importance of the link between energetic status and mechanical function is highlighted by the fact 
that maximum CPO is the strongest predictor of mortality in heart failure [1]. Indeed, the hypotheses for mecha-
nisms underlying age-dependent changes to myocardial mechano-energetic function tested here were formulated 
based on previous theoretical analysis of the link between energy metabolite levels and mechanical function of the 
heart in cardiac decomposition and failure [6, 7]. While these results do not suggest that the phenotypes are iden-
tical, they do suggest fundamental similarities in terms of mechanisms impeding myocardial energetics and me-
chanical-energetic coupling.  
Since the present model lacks an explicit representation of the mechanistic effects of metabolic/energetic state on 
myocardial mechanics, predictions of maximum cardiac power hinge on the simplifying assumption of constant 
efficiency (Equation 6). An alternative to hypothesis #2 above would be that cardiac efficiency decreases with 
age. However, our simulations suggest that this alternative may not be a major contributor to reductions in maxi-
mal CPO with aging. If mechanical efficiency were to markedly go down with age, then maximal CPO would 
drop with age even more than predicted by the present model, which assumes constant efficiency. Future studies 
investigating the direct mechanistic link between energetics and muscle dynamics will require the development of 
a cardiomyocyte mechanics model that accounts for the effects of energetic state and is parameterized to represent 
human myocytes. 
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Table 1: Population model parameters 
? ??????????? ?????? ?????
?? ????????????????????????????????????????
?????????
????? ???????????????
??? ????????????????????????????????????
?????????????
?????? ???????????????
??? ??????????????????????????????????????????
?????????
?????? ???????????????
a ?????????????????????????????? ????????
????????????? ???????????????????????????????
?????? ????????????????????
p ?????????????????????????????? ????????
????????????????????????????????????
?????? ????????????????????
c ?????????????????????????????? ??????????
????????????? ???????????????????????????????
???????? ????????????????????
??? ??????????????????????????????????? ????????
???????????????????????
????? ?????????
?? ??????????????????????????????????? ????????
???????????????????????
????? ?????????
??? ?????????????????????????? ?????????? ????????
???????????????????????
????? ?????????
???? ????????????????????????????????????????
???? ???????????????????????????????
????? ?????????
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Figure Legends 
Figure 1. Myocardial cellular energetics. Population model predictions of myocardial energy metabolite levels 
are plotted as functions of ??? ?. Model-predicted CrP/ATP, cytoplasmic inorganic phosphate concentration 
[Pi]c, cytoplasmic ATP concentration [ATP]c, and cytoplasmic ADP concentration [ADP]c are plotted for a popu-
lation of 20 year-old female subjects. The light shaded areas represent the 90% confidence range from the popula-
tion prediction for each variable; the dark shaded areas represent the 50% confidence range; and the solid line rep-
resents population mean. 
Figure 2. Changes in resting-state myocardial cellular energetics with age. Population model predictions of 
resting-state myocardial energy metabolite levels are plotted as functions age. Model-predicted CrP/ATP (panel 
A), total ATP (panel B), total CrP (panel C), Gibbs free energy of ATP hydrolysis (panel D), cytoplasmic ADP 
concentration [ADP]c, and cytoplasmic inorganic phosphate concentration [Pi]c (panel F), are compared to data 
from Köstler et al. [22] and Jakovljevic et al. [3]. The light shaded areas represent the 90% confidence range from 
the population prediction for each variable; the dark shaded areas represent the 50% confidence range; and the 
solid line represents population mean. Data from individual subjects are plotted as red dots. 
Figure 3: Predicted maximum left ventricular CPO as function of age. Both panels plot the population model 
predictions of maximum left-ventricular power output as functions age. The left panel shows observations from 
Jakovljevic et al. [3], with data from individual subjects plotted as individual data points. The right panel plots the 
means (open squares) and standard deviations (red lines) for the three age groups observed by Jakovljevic et al.
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